A team of researchers from the Universities of Amsterdam and Zurich together with the Swiss company Allocyte Pharmaceuticals have for the first time been able to discover allosteric sites in a type of cell surface receptor called integrin.
Click here for original story, Novel computational approach reveals previously inaccessible druggable pockets
Source: Phys.org